New gout drug shows promise in major trial
Disease control
Completed
This study tested whether a new medication called ABP-671 is safe and effective at lowering uric acid in people with gout. It involved 300 adults and compared different doses of ABP-671 against a placebo (inactive pill) and a standard gout medicine (allopurinol). The main goal wa…
Phase: PHASE2, PHASE3 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC